{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T12:29:58Z","timestamp":1785846598489,"version":"3.56.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2018,12,11]],"date-time":"2018-12-11T00:00:00Z","timestamp":1544486400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Orthop Trauma Surg"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1007\/s00402-018-3089-4","type":"journal-article","created":{"date-parts":[[2018,12,11]],"date-time":"2018-12-11T05:01:54Z","timestamp":1544504514000},"page":"597-604","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Prevention of postoperative bleeding in hip fractures treated with prosthetic replacement: efficacy and safety of fibrin sealant and tranexamic acid. A randomised controlled clinical trial (TRANEXFER study)"],"prefix":"10.1007","volume":"139","author":[{"name":"the TRANEXFER Group","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcos","family":"Jordan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Aguilera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Carlos","family":"Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo","family":"Castill\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00f3nica","family":"Salom\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Antonio","family":"Hern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonardo","family":"Ruiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Maria","family":"Mora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pilar","family":"Camacho-Carrasco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvi","family":"Prat-Fabregat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alba","family":"Bosch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ainhoa","family":"Rodriguez-Arias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5836-1138","authenticated-orcid":false,"given":"Mar\u00eda Jos\u00e9","family":"Mart\u00ednez-Zapata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,12,11]]},"reference":[{"key":"3089_CR1","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1093\/aje\/kwp266","volume":"170","author":"SE Bentler","year":"2009","unstructured":"Bentler SE, Liu L, Obrizan M, Cook EA, Wright KB, Geweke JF, Chrischilles EA, Pavlik CE, Wallace RB, Ohsfeldt RL, Jones MP, Rosenthal GE, Wolinsky FD (2009) The aftermath of hip fracture: discharge placement, functional status change, and mortality. Am J Epidemiol 170:1290\u20131299","journal-title":"Am J Epidemiol"},{"key":"3089_CR2","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1302\/0301-620X.80B2.7762","volume":"80","author":"BR Singer","year":"1998","unstructured":"Singer BR, McLauchlan GJ, Robinson CM (1998) Epidemiology of fractures in 15000 adults: the influence of age and gender. J Bone Jt Surg Br 80:243\u2013248","journal-title":"J Bone Jt Surg Br"},{"key":"3089_CR3","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1016\/S0140-6736(96)04330-9","volume":"348","author":"JL Carson","year":"1996","unstructured":"Carson JL, Duff A, Poses RM, Berlin JA, Spence RK, Trout R et al (1996) Effect of anaemia and cardiovascular disease on surgical mortality and morbility. Lancet 348:1055\u20131060","journal-title":"Lancet"},{"key":"3089_CR4","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1213\/ANE.0b013e31825b6824","volume":"115","author":"M Kirksey","year":"2012","unstructured":"Kirksey M, Lin Chiu Y, Ma Y, Gonzalez Della Valle A, Poultsides L, Gerner P, Memtsoudis SG (2012) Trends in in-hospital major morbidity and mortality after total joint arthroplasty: United States 1998\u20132008. Anesth Analg 115:321\u2013327","journal-title":"Anesth Analg"},{"key":"3089_CR5","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1097\/ALN.0b013e3181e08e97","volume":"113","author":"DR Spahn","year":"2010","unstructured":"Spahn DR (2010) Anemia and patient blood management in hip and knee surgery. A systematic review of the literature. Anesthesiology 113:482\u2013495","journal-title":"Anesthesiology"},{"key":"3089_CR6","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1055\/s-2007-996127","volume":"23","author":"S Okamoto","year":"1997","unstructured":"Okamoto S, Hijikata-Okunomiya A, Wanaka K et al (1997) Enzyme controlling medicines: introduction. Semin Thromb Hemost 23:493\u2013501","journal-title":"Semin Thromb Hemost"},{"key":"3089_CR7","doi-asserted-by":"publisher","first-page":"2404","DOI":"10.1016\/0268-960X(91)90015-5","volume":"5","author":"M Brennan","year":"1991","unstructured":"Brennan M (1991) Fibrin glue. Blood Rev 5:2404","journal-title":"Blood Rev"},{"key":"3089_CR8","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.ijsu.2016.10.022","volume":"36","author":"J Li","year":"2016","unstructured":"Li J, Li HB, Zhai XC, Qin-Lei, Jiang XQ, Zhang ZH (2016) Topical use of topical fibrin sealant can reduce the need for transfusi\u00f3n, total blood loss and the volumen of drainage in total knee and hip arthroplasty: a systematic review and meta-analysis of 1489 patients. Int J Surg 36:127\u2013137","journal-title":"Int J Surg"},{"key":"3089_CR9","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1007\/s00402-015-2232-8","volume":"135","author":"X Aguilera","year":"2015","unstructured":"Aguilera X, Mart\u00ednez-Zapata MJ, Hinarejos P, Jord\u00e1n M, Leal J, Gonz\u00e1lez JC, Monllau JC, Celaya F, Rodr\u00edguez-Arias A, Fern\u00e1ndez JA, Pelfort X, Puig-Verdie Ll (2015) Topical and intravenous tranexamic acid reduce blood loss compared to routine hemostasis in total knee arthroplasty: a multicenter, randomized, controlled trial. Arch Orthop Trauma Surg 135:1017\u20131025","journal-title":"Arch Orthop Trauma Surg"},{"key":"3089_CR10","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1302\/0301-620X.96B8.33745","volume":"96","author":"S Alshryda","year":"2014","unstructured":"Alshryda S, Sukeik M, Sarda P, Blenkinsopp J, Haddad FS, Mason JM (2014) A systematic review and meta-analysis of the topical administration of tranexamic acid in total hip and knee replacement. Bone Jt J 96:1005\u20131015","journal-title":"Bone Jt J"},{"key":"3089_CR11","doi-asserted-by":"publisher","first-page":"2503","DOI":"10.2106\/JBJS.I.01518","volume":"92","author":"J Wong","year":"2010","unstructured":"Wong J, Abrishami A, El Beheiry H, Mahomed N, Davey JR, Gandhi R et al (2010) Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty. J Bone Jt Surg Am 92:2503\u20132513","journal-title":"J Bone Jt Surg Am"},{"key":"3089_CR12","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1302\/0301-620X.89B3.17565","volume":"89","author":"DO Molloy","year":"2007","unstructured":"Molloy DO, Archbold HA, Ogonda L, McConway J, Wilson RK, Beverland DE (2007) Comparision of topical fibrin spray and tranexamic acid on blood loss after total knee replacement: a prospective, randomized controlled trial. J Bone Jt Surg Br 89:306\u2013309","journal-title":"J Bone Jt Surg Br"},{"key":"3089_CR13","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1177\/230949900601400202","volume":"14","author":"M Mawatari","year":"2006","unstructured":"Mawatari M, Higo T, Tsutsumi Y, Shigematsu M, Hotokebuchi T (2006) Effectiveness of autologous fibrin tissue adhesive in reducing postoperative blood loss during total hip arthroplasty: a prospective randomised study of 100 cases. J Orthopaedic Surg 14:117\u2013121","journal-title":"J Orthopaedic Surg"},{"key":"3089_CR14","first-page":"437","volume":"45","author":"M Sadeghi","year":"2007","unstructured":"Sadeghi M, Mehr-Aein A (2007) Does a single bolus dose of tranexamic acid reduce blood loss and transfusion requirements during hip fracture surgery? A prospective study randomized double blind study in 67 patients. Acta Medica Iranica 45:437\u2013442","journal-title":"Acta Medica Iranica"},{"key":"3089_CR15","doi-asserted-by":"crossref","unstructured":"Zufferey PJ, Miquet M, Quenet S, Martin P, Adam P, Albaladejo P, Mismetti P, Molliex S for the investigators of the tranexamic acid in hip-fracture surgery (THIF) study (2010) Tranexamic acid in hip fracture sugery: a randomized controlled trial. Br J Anaesth 104: 23\u201330","DOI":"10.1093\/bja\/aep314"},{"key":"3089_CR16","first-page":"224","volume":"51","author":"SB Nadler","year":"1962","unstructured":"Nadler SB, Hidalgo JU. Bloch T (1962) Prediction of blood volume in normal human adults. Surgery 51:224\u2013232","journal-title":"Surgery"},{"key":"3089_CR17","doi-asserted-by":"publisher","first-page":"660","DOI":"10.3109\/17453674.2011.623568","volume":"82","author":"JS Mc Connell","year":"2011","unstructured":"Mc Connell JS, Shewale S, Munro NA, Shah K, Deakin AH, Kinninmonth AWG (2011) Reduction of blood loss in primary hip arthroplasty with tranexamic acid or fibrin spray. A randomized controlled trial. Acta Orthop 82:660\u2013663","journal-title":"Acta Orthop"},{"key":"3089_CR18","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1177\/039463201302600118","volume":"26","author":"F Randelli","year":"2013","unstructured":"Randelli F, Banci L, Ragone V, Pasevi M, Randelli G (2013) Effectiveneness of fibrin sealant after cementless total hip replacement: a double blind randomized controlled trial. Int J Immunopathol Pharmacol 26:189\u2013197","journal-title":"Int J Immunopathol Pharmacol"},{"key":"3089_CR19","doi-asserted-by":"publisher","first-page":"1969","DOI":"10.2106\/JBJS.L.00908","volume":"95","author":"S Alshryda","year":"2013","unstructured":"Alshryda S, Mason J, Sarda P, Nargol A, Cooke N, Ahmad H, Tang S, Logishetty R, Vaghela M, McPartlin L, Hungin APS (2013) Topical (intra-articular) tranexamic acid reduces blood loss and transfusion rates following total hip replacement. A randomized controlled trial (TRANX-H). J Bone Joint Surg Am 95:1969\u20131974","journal-title":"J Bone Joint Surg Am"},{"key":"3089_CR20","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1016\/j.arth.2013.06.011","volume":"28","author":"G Konig","year":"2013","unstructured":"Konig G, Hamlin BR, Waters JH (2013) Topical tranexamic acid reduces blood Loss and transfusions rates in total hip and total knee arthroplasty. J Arthroplasty 28:1473\u20131476","journal-title":"J Arthroplasty"},{"key":"3089_CR21","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1016\/j.arth.2013.10.005","volume":"29","author":"JG Martin","year":"2014","unstructured":"Martin JG, Cassatt KB, Kincaid-Cinnamon KA, Estendorf DS, Garton AS, Lemke JH (2014) Topical administration of tranexamic acid in primary total hip and knee arthroplasty. J Arthroplasty 29:889\u2013894","journal-title":"J Arthroplasty"},{"key":"3089_CR22","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.arth.2014.07.019","volume":"29","author":"W Wei","year":"2014","unstructured":"Wei W, Wei B (2014) Comparison of topical and intravenous tranexamic acid on blood loss and transfusion rates in total hip arthroplasty. J Arthroplasty 29:113\u2013116","journal-title":"J Arthroplasty"},{"key":"3089_CR23","doi-asserted-by":"publisher","first-page":"2452","DOI":"10.1016\/j.arth.2014.03.032","volume":"29","author":"C Yue","year":"2014","unstructured":"Yue C, Kang P, Yang P, Xie J, Pei F (2014) Topical application of tranexamic acid in primary total hip arthroplasty: a randomized double-blind controlled trial. J Arthroplasty 29:2452\u20132456","journal-title":"J Arthroplasty"},{"key":"3089_CR24","doi-asserted-by":"publisher","first-page":"48","DOI":"10.4103\/0259-1162.128908","volume":"8","author":"WM Emara","year":"2014","unstructured":"Emara WM, Moez KK, Elkhouly AH (2014) Topical versus intravenous tranexamic acid as a blood conservation intervention for reduction of postoperative bleeding in hemiarthroplasty. Anaesth Essays Res 8:48\u201353","journal-title":"Anaesth Essays Res"},{"key":"3089_CR25","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1007\/s00264-016-3195-2","volume":"41","author":"JS Kang","year":"2016","unstructured":"Kang JS, Moon KH, Kim BS, Yang SJ (2016) Topical administration of tranexamic acid in hip arthroplasty. Int Orthop 41:259\u2013263","journal-title":"Int Orthop"}],"container-title":["Archives of Orthopaedic and Trauma Surgery"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00402-018-3089-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00402-018-3089-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00402-018-3089-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,12,10]],"date-time":"2019-12-10T19:13:37Z","timestamp":1576005217000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00402-018-3089-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12,11]]},"references-count":25,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,5]]}},"alternative-id":["3089"],"URL":"https:\/\/doi.org\/10.1007\/s00402-018-3089-4","relation":{},"ISSN":["0936-8051","1434-3916"],"issn-type":[{"value":"0936-8051","type":"print"},{"value":"1434-3916","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12,11]]},"assertion":[{"value":"6 July 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 December 2018","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"On behalf of all authors, the corresponding author states that there is no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures involving human participants were in accordance with the ethical standards of the institutional and\/or national Research Ethics Committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}